Market open · Delayed intraday data · 3:40 PM ET
Last update: Oct 19, 2026, 3:32 PM ET

Technology

Snowflake (SNOW) Jumps 16% on a Q2 Beat-and-Raise as a Software Pop Fades

Snowflake jumped as much as 26% intraday to a 52-week high of $384.56, then pared the gain to close up about 16.5% at $356.47, after reporting fiscal second-quarter results the evening before that beat and — the part that moves stocks — raised full-year guidance. Product revenue re-accelerated to about 37% growth ($1.49 billion), adjusted earnings of about $0.62 topped the ~$0.45 expected, and management lifted its full-year product-revenue target to roughly $6.07 billion while widening its margin outlook. The beat-and-raise sparked a sympathy surge across software — Datadog and MongoDB edged higher — on the idea that AI is a tailwind rather than a threat, but that broader enthusiasm largely faded by the close, leaving both peers up only about 2.5% while Snowflake held its gain. The catch is the price: after a ~55% year, Snowflake trades near 15 times forward sales and is still GAAP-unprofitable on heavy stock comp, though it closed somewhat below the average analyst target even after a wave of same-day target increases.

By Roberto LiccardoPublished (ET)8 min readSNOW
An abstract visualization of a large-scale cloud data center with glowing blue server racks and flowing streams of data, representing Snowflake's cloud data platform.

Why Snowflake stock surged — a beat-and-raise to a 52-week high

On Thursday, September 3, 2026, Snowflake (NYSE: SNOW) jumped as much as 26% intraday to a 52-week high of $384.56, then pared the gain to close up about 16.5% at $356.47, from a $305.84 prior close [1]. The catalyst was concrete and freshly dated: after the close the evening before, Snowflake reported fiscal second-quarter results that beat on both revenue and earnings and, crucially, raised full-year guidance [2]. It was the kind of clean beat-and-raise the market had been waiting for from a high-multiple software name — and it sparked a sympathy surge across enterprise-software stocks, though much of that broader enthusiasm faded by the close [5].

Inside the quarter: re-accelerating growth

The headline was growth that sped up rather than slowed. Product revenue — the core measure of Snowflake's consumption business — rose about 37% year over year to roughly $1.49 billion, an acceleration and the company's second consecutive quarter of record sequential dollar growth; total revenue was about $1.55 billion, up ~35% [2]. Adjusted (non-GAAP) earnings came in near $0.62 a share, well ahead of the roughly $0.45 analysts expected [2]. Management then did the thing that moves stocks most: it raised the full-year product-revenue outlook to about $6.07 billion (from roughly $5.84 billion in May) and lifted its adjusted operating-margin target to about 14.5% [2]. Profitability is improving alongside growth — non-GAAP operating margin expanded more than 400 basis points to about 15% — and the AI story is showing tangible adoption, with Snowflake's AI coding agent reaching roughly 9,100 accounts, up about 2,000 in the quarter [2]. Growth, margins and AI traction all moving the right way at once is what sent the shares soaring.

Two-panel chart titled 'Snowflake (SNOW): a beat-and-raise, while the sympathy pop faded.' The left panel shows September 3 closing stock moves: Snowflake up about 16.5%, Datadog (DDOG) up about 2.6%, MongoDB (MDB) up about 2.4%, and the software ETF (IGV) up about 3.4% — Snowflake held its gain on its own results while the sympathy lift in peers was small and largely faded by the close. The right panel shows Snowflake's share price — a 52-week low of $118, a prior close of about $306, and a September 3 close of about $356 (after an intraday high of $385) — noting the roughly 16.5% earnings-day gain. A stat strip shows the 16.5% closing move, product revenue up 37%, the raised full-year product-revenue guidance of about $6.07 billion, four same-day analyst target increases (plus a William Blair Buy reiteration), and a $124 billion market value.
Snowflake jumped as much as ~26% intraday but closed up about 16.5% — holding its gain on its own beat-and-raise, while a modest sympathy lift in peers largely faded by the close: Datadog and MongoDB rose only modestly and finished up about 2.5%, with the software ETF (IGV) up about 3.4%. The initial enthusiasm reflected easing fears that AI would disrupt software. Sources: StockAnalysis; company release; market data, Sep 2026.

Priced for a lot

The bull case still has to contend with the price. Even before Thursday, Snowflake had climbed about 55% over the past year, and the earnings-day gain left it trading at roughly 15 times forward sales — a demanding multiple, and one that assumes years of 25%-plus growth [3]. The company is still unprofitable on a GAAP basis (a trailing net loss of about $1.1 billion, weighed down by heavy stock-based compensation), though that understates the cash economics: Snowflake generates roughly $1.2 billion of free cash flow a year at a 67% gross margin [3]. Even after the jump, the shares closed somewhat below the average analyst price target near $395 (captured that session, and climbing as firms raised targets), so the Street still sees room — the debate is whether re-accelerating growth and expanding margins justify paying such a premium multiple.

Why it matters

Snowflake's jump is about more than one quarter. For two years, the fear hanging over software has been that generative AI would disrupt incumbent platforms — that AI could hollow out the value of databases, analytics and SaaS tools. September 3 was, for a session, the market voting the other way: Snowflake's beat-and-raise sparked a sympathy surge across data-software names — Datadog and MongoDB edged higher — on the idea that AI is a tailwind, not a threat, since enterprises adopting AI need more data infrastructure, more observability and more managed databases, not less. But that broader enthusiasm largely faded by the close; it was Snowflake's own numbers that held. Snowflake, whose whole pitch is to be the place enterprise data lives and where AI models are fed, is a natural bellwether for the AI-tailwind thesis — and holding a ~16.5% gain while peers managed only small gains was the clearest sign that its blowout quarter, more than the sector narrative, was the durable signal.

Snowflake held; the sympathy pop faded, in one cross-section

The same-day tape shows Snowflake held its earnings gain while the sympathy surge in its peers largely faded by the close [5]:

Name (ticker)Sept 3, 2026Read-through
SNOW — Snowflake≈+16.5% (close)Fiscal-Q2 beat-and-raise; product revenue +37%, guidance lifted — held its gain [1][2]
DDOG — Datadog≈+2.6% (close)A modest sympathy gain 14 rose only single digits intraday, gave part back [5]
MDB — MongoDB≈+2.4% (close)Revenue up ~30% to ~$772M, but its intraday pop also faded [5]
IGV — Software ETF≈+3.4%The broad software group finished up modestly [5]

Snowflake closing up ~16.5% on its own beat-and-raise while the peers that rose in sympathy finished up only ~2.5% is the signal: the durable move was company-specific, and the broader AI-software enthusiasm proved thin outside the name that actually delivered [5].

What the Street thinks

The sell side rushed to raise targets. The consensus is a Strong Buy, and even after the pop the average 12-month target of about $395 — captured that session, and rising as firms lifted estimates — sat about ~11% above the closing price, in a wide range from a low near $110 to a high of $525 [6]. On the morning after the print, a wave of firms lifted their targets: Scotiabank's Patrick Colville to $440 (from $320), Cantor Fitzgerald's Thomas Blakey to $430 (from $405), Raymond James's Adam Tindle to $425 (from $275), and Deutsche Bank's Brad Zelnick to $400 (from $350), while William Blair's Jason Ader reiterated a Buy [6]. That the average target still sits just above the price, even after those increases, is the tension in a single number: analysts love the story but the stock has already moved a long way to meet them.

What to watch

  • Consumption trends. Whether product-revenue growth holds in the mid-30s%, the clearest signal that AI workloads are driving usage [2].
  • Margins and stock comp. Continued non-GAAP margin expansion, and whether GAAP losses narrow as stock-based compensation moderates [3].
  • AI monetization. Adoption of Snowflake's AI features and agents, the proof that the "AI tailwind" translates into paid consumption [2].
  • Valuation versus targets. Whether growth can carry a stock that already trades near consensus and at ~16x sales. Moves are tracked on the SNOW stock page [1].

Illustrative valuation sensitivity

The scenarios below are anchored to Snowflake's growth and margin trajectory and to the analyst target distribution (low near $110, average ~$395, high $525) [6], turning on how durably the AI-data thesis drives consumption. They are a descriptive, author-weighted exercise — not a forecast, target, recommendation, or intrinsic fair-value calculation — with subjective weights that sum to 100%.

ScenarioIllustrative priceWeightKey drivers
Upside~$49030%Growth holds above 30% as AI workloads compound, margins keep expanding, and the multiple stays rich as the stock re-rates toward the bullish targets [6].
Middle~$40040%Strong but decelerating growth carries the stock toward the average target, with the multiple roughly stable as it consolidates the earnings gains [6].
Downside~$30030%The AI-software enthusiasm cools or growth slows, and a ~16x forward-sales multiple compresses back toward pre-earnings levels [3].

Weighting those (0.30 × $490 + 0.40 × $400 + 0.30 × $300) gives an author-weighted reference value near $397, above Thursday's ~$356 close and roughly in line with the ~$395 consensus target [1][6] — reflecting a high-growth franchise the market has just re-rated on a strong quarter, with the debate now about how much of the AI-data upside is already priced. This is a Street-target-and-growth-based scenario exercise and descriptive analysis of a news move, not investment advice.

SNOW data snapshot — September 3, 2026

FigureValueAs-of / source
Close$356.47, up ~16.5% on the day (after an intraday high of $384.56, a 52-week high) — settled closeThu, Sep 3, 2026 — StockAnalysis [1]
Prior close / open / range$305.84 prior close; gapped open $379.23; day range $370.30–$384.00Sep 3, 2026 [1]
52-week range / trend$118.30–$384.00; up ~55% over the past year; well above its ~$296 50-day and ~$219 200-day averages; RSI ≈71 (overbought)As of Sep 3 [3]
Market cap / EV≈$124B at the close (346.6M shares); enterprise value ≈$124B; beta ≈1.33Sep 3 — StockAnalysis [3]
Valuation≈23× trailing sales (≈15× forward) at the close; GAAP-unprofitable (trailing net loss ≈$1.1B on heavy stock comp), but ~$1.2B free cash flow; gross margin ≈67%Sep 3 — StockAnalysis [3]
Q2 results (reported Sep 2, after close)Product revenue ≈$1.49B (+37% YoY); total revenue ≈$1.55B (+35%); adjusted EPS ≈$0.62 vs ~$0.45 est; non-GAAP operating margin ≈15% (+400bps YoY)Fiscal Q2 FY2027 — company [2]
GuidanceRaised full-year product-revenue outlook to ≈$6.07B (from ~$5.84B in May); Q3 product-revenue guide ≈$1.59B; FY adjusted operating margin ≈14.5%Sep 2, 2026 — company [2]
Same-day peers (close)DDOG +~2.6%, MDB +~2.4% (single-digit intraday highs, partly faded); IGV software ETF +~3.4% — a modest sympathy lift; SNOW vastly outperformedSep 3 [5]
Analyst viewConsensus Strong Buy (35 Strong Buy / 10 Buy / 7 Hold of 52), avg target ≈$395 — ~6% above the price, range ~$110–$525; same-day target raises from Scotiabank ($440), Cantor ($430), Raymond James ($425), Deutsche Bank ($400)Sep 2026 — StockAnalysis / analyst notes [6]

Snowflake (SNOW) stock FAQ

Why did Snowflake (SNOW) stock surge on September 3, 2026?

Snowflake jumped as much as 26% intraday to a 52-week high of $384.56, then pared the gain to close up about 16.5% at $356.47, after reporting fiscal second-quarter results after the close the evening before that beat on revenue and earnings and raised full-year guidance. Product revenue re-accelerated to about 37% growth (roughly $1.49 billion), adjusted earnings of about $0.62 a share topped the roughly $0.45 expected, and management lifted its full-year product-revenue outlook to about $6.07 billion. The beat-and-raise sparked a sympathy surge across software stocks intraday, though much of that broader move faded by the close.

What were the key numbers in Snowflake's fiscal Q2?

Product revenue rose about 37% year over year to roughly $1.49 billion (an acceleration and a second straight quarter of record sequential dollar growth), and total revenue was about $1.55 billion, up ~35%. Adjusted (non-GAAP) earnings were about $0.62 a share versus the roughly $0.45 analysts expected. Non-GAAP operating margin expanded more than 400 basis points to about 15%. Management raised its full-year product-revenue target to about $6.07 billion (from roughly $5.84 billion in May) and guided Q3 product revenue to about $1.59 billion.

Why did other software stocks like Datadog and MongoDB also rise?

Snowflake's beat-and-raise sparked a sympathy surge across enterprise-software names intraday, on the idea that AI is a tailwind rather than a threat — enterprises deploying AI need more data infrastructure, observability and managed databases. Datadog and MongoDB (whose revenue rose ~30% to ~$772 million) rose only modestly. But that broader enthusiasm largely faded through the session: Datadog and MongoDB closed up only about 2.6% and 2.4%, while Snowflake held a ~16.5% gain on its own results — a sign the durable move was company-specific rather than a lasting sector re-rating.

Is Snowflake profitable?

It depends on the measure. Snowflake is profitable on an adjusted (non-GAAP) basis and generates roughly $1.2 billion of annual free cash flow at a gross margin near 67%. But it remains unprofitable on a GAAP basis, with a trailing net loss of about $1.1 billion, largely because of heavy stock-based compensation. The improving non-GAAP operating margin — up more than 400 basis points year over year to about 15% — is a big part of the bull case, but the GAAP losses and stock comp are a key part of the bear case.

Is Snowflake stock expensive after the jump?

By most measures, yes. After a roughly 55% gain over the past year and a 16.5% earnings-day close, Snowflake trades at about 15 times forward sales — a demanding multiple that assumes years of 25%-plus growth. It closed somewhat below the average analyst price target of about $395 (even after a wave of same-day target increases), so the Street still sees modest upside. The bull case rests on durable, AI-driven consumption growth and expanding margins justifying the premium; the bear case is that the price already reflects near-flawless execution, and the fact that the small, fading sympathy lift in peers hints the broader enthusiasm was thin.

What do analysts think of Snowflake stock now?

Coverage is overwhelmingly bullish. The consensus is a Strong Buy — 35 Strong Buy and 10 Buy of 52 analysts, with 7 Holds and no Sells — and the average 12-month target is about $395, in a range from a low near $110 to a high of $525. After the quarter, several firms raised targets, including Scotiabank's Patrick Colville (to $440), Cantor Fitzgerald's Thomas Blakey (to $430), Raymond James's Adam Tindle (to $425) and Deutsche Bank's Brad Zelnick (to $400). Notably, even after those increases the average target sits only about 6% above the post-earnings price.

View all research →
An abstract visualization of a rising stock chart over a molten-aluminum and smelter motif in warm silver and amber tones, representing Alcoa's jump after a strong Q3 earnings beat met a tight aluminum market.
Stock AnalysisOctober 16, 2026 · 9 min read

Alcoa (AA) Jumps ~7% as a Strong Q3 Meets a Tight Aluminum Market

Alcoa rose about 7% to roughly $43.20 on October 16, in the first full session after reporting third-quarter results after the close on October 15. Two forces drove it. First, a genuine earnings beat: adjusted earnings of about $1.82 a share topped the roughly $1.54 expected, with net income of $483 million and free cash flow of $472 million, powered by record production, the completed Alumar smelter restart, and higher alumina prices that offset lower aluminum prices and higher carbon costs — though revenue of about $3.7 billion slightly missed and adjusted EBITDA fell sequentially. Second, and just as important, a broad bid for aluminum stocks on a tightening-supply narrative: peers Century Aluminum (+4.5%) and Kaiser Aluminum (+2.4%) and the materials sector (+1.5%) all rose while the market was flat, so Alcoa led a group move rather than rallying alone — a point underscored by Barclays' Overweight initiation two days earlier citing constrained supply through 2026. Alcoa is a cheap, high-beta cyclical, trading around 7 times earnings and still about 49% below its intra-year high, with earnings that swing on volatile metal prices and a tariff overhang. Analysts carry a Buy consensus and an average target near $60, so the debate is less about execution — which was strong — than about where aluminum prices and trade policy go next.

An abstract visualization of a falling stock chart over a pharmaceutical and medical-cross motif in deep blue and red tones, representing Johnson & Johnson's drop after a Q3 beat-and-raise overshadowed by a large talc-litigation charge.
Stock AnalysisOctober 13, 2026 · 10 min read

Johnson & Johnson (JNJ) Falls ~6% Despite a Q3 Beat-and-Raise

Johnson & Johnson fell about 6% to roughly $247.63 on October 13 after third-quarter results — an unusually large move for a defensive Dow stalwart with a beta near 0.21. The strange part: at the headline it was a beat-and-raise. Adjusted earnings of $2.59 topped estimates and the company raised full-year guidance, lifting adjusted EPS to about $11.10 at the midpoint and putting sales on track to cross $100 billion for the first time. The stock fell anyway, and the main reason was the device business: MedTech sales of about $8.6 billion grew just 2.5% and missed Wall Street's estimate for a second straight quarter, against a strong 7.9% for the Innovative Medicine drug division. On top of that, the guidance raise was modest, the adjusted 'beat' was still down about 7.5% from a year earlier, and the stock had run up about 30% over the past year, leaving it priced for good news. A separate, largely accounting story grabbed headlines: reported GAAP net income collapsed to about $210 million (EPS of $0.09) on roughly $7.6 billion of special charges, about $5.5 billion of it a talc-litigation provision — but that settlement had been announced back in July, so the quarter merely booked the charge rather than breaking news. Pharma peers and the market barely moved, confirming a company-specific drop. The trailing P/E near 30 looks alarming but is distorted by the charges; on adjusted earnings the stock trades closer to 22 times forward. Analysts keep a Buy consensus with an average target near $280, above the price.

An abstract visualization of a falling stock chart over a quantum-circuit and network-security motif in cool violet and red tones, representing IonQ's drop on its all-stock Elisity cybersecurity acquisition.
Stock AnalysisOctober 12, 2026 · 10 min read

IonQ (IONQ) Falls ~9% on a $1.3B All-Stock Cybersecurity Acquisition

IonQ fell about 9% to roughly $36 on October 12 on a day it announced a definitive agreement to acquire Elisity, a zero-trust cybersecurity company, in an all-stock deal worth up to $1.3 billion. The counterintuitive part is the point: a stock dropping on its own acquisition. The all-stock structure is why — IonQ's share count is already up about 50% over the past year as it funds an acquisition-and-fundraising spree largely with stock, and Elisity is its third billion-dollar-scale deal in roughly 16 months, after the mostly-stock Oxford Ionics purchase and the cash-and-stock SkyWater acquisition. The strategic logic is forward-looking (pairing post-quantum cryptography with Elisity's zero-trust platform to sell 'quantum-era' security), but the market read the news as more dilution and more strategic sprawl from a pre-profit company valued near $14 billion on just $246 million of revenue — about 58 times sales, with an operating margin near negative 380%. A sign of company-specific pressure: IonQ fell about 9% while quantum peers Rigetti and D-Wave fell closer to 5.5% and the Nasdaq-100 slipped under 1% — more than the sector alone would explain. Wall Street stays overwhelmingly bullish on the long-term quantum roadmap — a Strong Buy consensus with an average target far above the price — which is exactly why a story stock like this swings so violently on news.